Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_assertion type Assertion NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_head.
- NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_assertion wasGeneratedBy ECO_0000203 NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_provenance.
- NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_assertion wasDerivedFrom befree-2016 NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_provenance.
- NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_assertion SIO_000772 1380280 NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_provenance.
- NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_assertion evidence source_evidence_literature NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_provenance.
- NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_assertion description "[The results in different types of leukaemia were (number of patients with detectable mdr1 RNA/total number of patients; median number of transcripts per cell in samples with detectable mdr1 RNA); de novo untreated acute myelocytic leukaemia (AML): 20/44; 0.7, secondary acute myelocytic leukaemia: 8/13; 1.1, acute lymphocytic (ALL) and undifferentiated leukaemia: 5/14; 0.6, relapsed leukaemia: 7/15; 0.7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412599.RAKgbdBxL7wj55-Jpr_GcRJTGoVreoWimW5AJvcqCoGco130_provenance.